- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 127,780 | 29.07.24 22:00:07 | +2,520 | +2,01% | 127,430 | 128,000 | 127,235 | 125,260 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 108,750 | 29.07.24 22:00:07 | +1,610 | +1,50% | 108,750 | 108,800 | 107,290 | 107,140 |
